Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations
A. Pacholewska, M. Lienhard, M. Brueggemann, H. Haenel, L. Bilalli, A. Koenigs, K. Becker, K. Koehrer, J. Kaiser, H. Gohlke, N. Gattermann, M. Hallek, C. D. Herling, J. Koenig, C. Grimm, , M. R. Schweiger
This study uses long-read transcriptome sequencing to analyze SF3B1 mutations in CLL and MDS patients, revealing common splicing alterations and their impact on disease prognosis.
bioRxiv · Jan 26, 2024Cancer Biology